welcomes you to the new, improved website!Data from the PARTNER trials were assessed regarding post-procedural prosthetic valve endocarditis (PVE) after transcatheter aortic valve replacement and surgical aortic valve replacement. The timing and rates of PVE were similar between the groups, and they had a similar high mortality.
You are here:
Prosthetic Valve Endocarditis after TAVR and SAVR: Insights from the PARTNER Trials
Submitted by: Mark Ferguson
Source: Circulation
Keywords:
Author(s): Matthew R. Summers, Martin B. Leon, Craig R. Smith, Susheel K. Kodali, Vinod H. Thourani, Howard C. Herrmann, Raj R. Makkar, Philippe Pibarot, John G. Webb, Jonathon Leipsic, Maria C. Alu, Aaron Crowley, Rebecca T. Hahn, Samir R. Kapadia, E. Murat Tuzcu, Lars Svensson, Paul C. Cremer, and Wael A. Jaber
